About Biogen
Industry:
Biotechnology
Founded:
1978
Founders:
Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert
Status:
Public (NASDAQ: BIIB)
Funding & Growth
Total Raised:
N/A
Valuation:
$35B+ market cap
Stage:
Public
Key Investors:
Public markets
✓ Pros
- • Leader in neuroscience
- • Cambridge, MA location
- • Strong MS portfolio
- • Pioneer in biotech
- • Good benefits
✗ Cons
- • Alzheimer's drug challenges
- • Recent restructuring
- • Stock volatility
- • Competitive landscape